Vaccine Manufacturing Innovation Centre

Of national importance for public health and future resilience, the Vaccine Manufacturing Innovation Centre (VMIC) will be the UK’s first vaccine development and manufacturing centre. The outbreak of the COVID-19 pandemic during the pre-planning stage of this project necessitated a rapidly accelerated construction programme to bring the facility into full operation by early 2021; ahead of its original scheduled date of 2022. Mobilising quickly, and at short notice, required a change to the conventional approach.

Once operational, the Vaccine Manufacturing Innovation Centre (VMIC) will develop new manufacturing processes in collaboration with industrial and academic users; following Good Manufacturing Practice for experimental vaccines, contract manufacture of vaccines and public health campaigns.

The centre is located on the Harwell Campus in Oxfordshire, established as one of the leading science and innovation campuses in Europe. We are providing Landscape Architecture, Ecology and Arboriculture services to support the pre-planning, design and construction of this 75,000sqft state-of-the-art facility. As part of these works we have developed a solution that delivers Biodiversity Net Gain.



Key details

Project name

Vaccine Manufacturing Innovation Centre (VMIC)



Harwell / VMIC



Harwell, Oxfordshire


Services provided

- Landscape Architecture

- Ecology & BNG Advice

- Arboriculture 


With planning negotiations in their infancy, the UK government agreed with the local planning authority to allow construction to commence on site whilst working through the planning process. We are working closely with the local planning authority whilst developing the detailed design to allay any concerns and ensure the final scheme meets wider planning considerations.

Located on a 5-acre plot within the heart of the Harwell Campus, the early establishment of a suitable and safe haul road was instrumental to achieving a quick start on site. We supported the feasibility and optioneering exercise with arboriculture and ecology inputs. 

To ensure we could continue to provide the necessary site support, we developed a strict COVID-19 Risk Assessment and acquired a Business Critical Activity permit which allowed our staff to safely undertake site inspections to facilitate programme continuity.



As an advanced centre of technology. the development extends beyond a straightforward build, requiring a complex fit-out.

Essential to the successful delivery of the VMIC is a united approach adopted by the whole project team. We are collaborating with the contractor, design team and local authority to ensure timely decisions on critical path matters, avoiding negative impact on the programme whilst also developing the detailed design for the external works.

The construction is progressing concurrently to the planning application and the project is on track to meet its accelerated delivery date. In the face of challenging times we are proud to use our expertise to solve problems that matter, helping to protect public health in years to come.


We say we solve problems that matter. And we do.

In challenging times we are proud to use our expertise to support the fast tracked delivery of this nationally significant - and the UK’s first - vaccine development and manufacturing centre.

Craig Thomson, Operational Director

Craig Thomson Testimonial.png

Project statistics

vaccine development and manufacturing centre in the UK
vaccine manufacturing facility
site in Harwell

Leading minds


Brilliant minds finding solutions to complex problems, made easy to understand. Making complex easy.

Get in touch

Your contact information:

All fields are mandatory *

Get in touch

Your contact information:

All fields are mandatory *